Department of Obstetrics and Gynaecology, Hôpital de Sacré-Coeur, Montreal, Canada.
1471-0528/asset/BJO_left.gif?v=1&s=0fb87361cdb6be25fdf05019eed6d47f5143f610)
1471-0528/asset/olbannerright.gif?v=1&s=3892ef16ff18d6834c302faf85268a49f5fc588f)
THE EFFECT OF ORAL RITODRINE ON MATERNAL AND FETAL CARBOHYDRATE METABOLISM
Article first published online: 23 AUG 2005
DOI: 10.1111/j.1471-0528.1976.tb00918.x
Issue
1471-0528/asset/cover.gif?v=1&s=b4e1d96c46e18c61210d584b63c13ee375cf562b "BJOG: An International Journal of Obstetrics & Gynaecology")
BJOG: An International Journal of Obstetrics & Gynaecology
Volume 83, Issue 9, pages 711–715, September 1976
Additional Information
How to Cite
Blouin, D., Murray, M. A. F. and Beard, R. W. (1976), THE EFFECT OF ORAL RITODRINE ON MATERNAL AND FETAL CARBOHYDRATE METABOLISM. BJOG: An International Journal of Obstetrics & Gynaecology, 83: 711–715. doi: 10.1111/j.1471-0528.1976.tb00918.x
Publication History
- Issue published online: 23 AUG 2005
- Article first published online: 23 AUG 2005
- Abstract
- References
- Cited By
Summary
The reported growth-promoting effects of the beta-sympathomimetic compound, ritodrine, have been investigated. The carbohydrate tolerance of eight pregnant women was found to be unaffected by treatment with oral ritodrine over a ten-week period. A further observation that the carbohydrate metabolism of the newborn infants of these women was within normal limits tends to discount the possibility that any growth-promoting action ritodrine may have on the fetus is mediated through a diabetogenic effect on the mother.